Increased expression of monocyte chemotactic protein-1 (MCP-1) has been indicated as a mechanism underlying leukocyte recruitment after liver injury. In this study we examined the temporal relationship between MCP-1 expression and the appearance of monocyte infiltration during acute liver injury. In addition, we tested the effects of vitamin E, a well known antioxidant, on these parameters. Rats were intoxicated with a single intragastric administration of CCl4 with or without pretreatment with vitamin E (a-tocopherol).
Methods
Monocyte chemotactic protein-1 expression was analyzed by northern blotting and in situ hybridization and monocyte infiltration was determined by ED-1 immunostaining. The results were quantitated by computerized image analysis. Expression of MCP-1 mRNA was significantly increased as early as 12 hours following injury, and progressively increased thereafter. In contrast, a significant increase in the number of ED-1 positive cells, an index of monocyte infiltration, was observed only 24 and 48 hours after injury.
Results
Vitamin E markedly reduced MCP-1 expression at the mRNA and protein levels, and caused a significant reduction in the number of monocyte/macrophages, indicating a role for oxidative stress in the induction of MCP-1 expression in vivo. Accordingly, in cultured hepatic stellate cells, different oxidative stress-related molecules increased MCP-1 mRNA.
Conclusions
These data suggest the existence of a direct relationship between MCP-1 expression and monocyte infiltration after acute liver injury, and that preventing the generation of oxidative stress-related molecules results in decreased expression and release of this chemokine.
LusterAD.Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med1998;338:436–45.
2.
ValenteAJ, GravesDT, Vialle-ValentinCE, DelgadoR, SchwartzCJ.Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry1988;27:4162–8.
3.
LoetscherP, SeitzM, Clark-LewisI, BaggioliniM, MoserB.Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J1994;8:1055–60.
4.
NegusRPM, StampGWH, RelfMG, BurkeF, MalikSTA, BernasconiS, AllavenaP, SozzaniS, MantovaniA, BalkwillFR.The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest1995;95:2391–6.
5.
Ylä-HerttualaS, LiptonBA, RosenfeldBE, SärkioiaT, YoshimuraT, LeonardEJ, WitzumJL, SteinbergD.Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA1991;88:5252–6.
6.
AntoniadesHN, Neville-GoldenJ, GalanopoulosT, KradinRL, ValenteAJ, GravesDT.Expression of monocyte chemoattractant protein 1 mRNA in human idiopatic pulmonary fibrosis. Proc Natl Acad Sci USA1992;89:5371–5.
7.
GrandalianoG, GesualdoL, RanieriE, MonnoR, MontinaroV, MarraF, SchenaFP.Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol1996;7:906–13.
LloydCM, MintoAW, DorfME, ProudfootA, WellsTNC, SalantDJ, Gutierrez-RamosJ-C. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med1997;185:1371–80.
10.
MarraF, ValenteAJ, PinzaniM, AbboudHE.Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest1993;92:1674–80.
11.
CzajaMJ, GeertsA, XuJ, SchmiedebergP, JuY.Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol1994;55:120–6.
12.
MarraF, DeFrancoR, GrapponeC, MilaniS, PastacaldiS, PinzaniM, RomanelliRG, LaffiG, GentiliniP.Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol1998;152:423–30.
13.
MarraF, ValenteAJ, GrandalianoG, AbboudHE.Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1. Potential role in liver injury. Hepatology1995;22:780–7.
14.
XuY, RojkindM, CzajaMJ.Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology1996;110:1870–7.
15.
MarraF, PastacaldiS, RomanelliRG, PinzaniM, TicaliP, CarloniV, LaffiG, GentiliniP.Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett. 1997;414:221–5.
16.
ParolaM, AlbanoE, AutelliR, BarreraG, BioccaME, ParadisiL, DianzaniMU.Inhibition of the high affinity Ca ATPase activity in rat liver plasma membranes following carbon tetrachloride intoxication. Chem-Biol Interact1990;73:103–19.
17.
MilaniS, GrapponeC, PellegriniG, SchuppanD, HerbstH, CalabròA, CasiniA, PinzaniM, SurrentiC.Undulin RNA and protein expression in normal and fibrotic human liver. Hepatology1994;20:908–16.
18.
CasiniA, PinzaniM, MilaniS, GrapponeC, GalliG, JezequelAM, SchuppanD, RotellaCM, SurrentiC.Regulation of extracellular matrix synthesis by transforming growth factor ß’ in human fat-storing cells. Gastroenterology1993;105:245–53.
19.
FriedmanSL.The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med1993;328:1828–35.
20.
EsterbauerH, SchaurRJ, ZollnerH.Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med1991; 11:81–128.
21.
BiasiF, AlbanoE, ChiarpottoE, CorongiuFP, PronzatoMA, MarinariUM, ParolaM, DianzaniMU, PoliG.In vivo and in vitro evidence concerning the role of lipid peroxidation in the mechanism of hepatocyte death due to carbon tertachloride. Cell Biochem Funct1991;9:111–8.
22.
CurzioM, EsterbauerH, Di MauroC, CecchiniG, DianzaniMU.Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Biol Chem Hoppe Seyler1986;367:321–9.
23.
LeonarduzziG, ScavazzaA, BiasiF, ChiarpottoE, CamandolaS, VogelS, DargelR, PoliG.The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta 1 expression in the mancrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J1997;11:889–94.
24.
DianzaniMU.4-Hydroxynonenal and cell signaling. Free Radic Res1998;28:553–60.
25.
ParolaM, PinzaniM, CasiniA, AlbanoE, PoliG, GentiliniA, GentiliniP, DianzaniMU.Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen al(I) gene expression and synthesis in human liver fat-storing cells. Biochem Biophys Res Commun1993;194:1044–50.
26.
CasiniA, CeniE, SalzanoR, BiondiP, ParolaM, GalliA, FoschiM, CaligiuriA, PinzaniM, SurrentiC.Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology1997;25:361–7.
27.
UedaA, OkudaK, OhnoS, ShiraiA, IgarashiT, MatsunagaK, FukushimaJ, KawamotoS, IshigatsuboY, OkuboT.NF-KB and Spl regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol1994;153:2052–63.
28.
SchreckR, RieberP, BauerlePA.Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-KB transcription factor and HIV-1. EMBO J1991;10:2247–58.
29.
LiuS-H, Degli EspostiS, YaoT, DiehlAM, ZernMA.Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology1995;22:1474–81.
30.
CanandolaS, ScavazzaA, LeonarduzziG, BiasiF, ChiarpottoE, AzziA, PoliG.Biogenic 4-hydroxy-2,3-noneal activates transcription factor AP-1 but not NF-KB in cells of the macrophage lineage. Biofactors1997;6:173–9.
31.
SatrianoJA, ShuldinerM, HoraK, XingY, SchlondorffD.Oxygen radicals as second messengers for expression of monocyte chemoattractant protein JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-a and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest1993;92:1564–71.
32.
LeeKS, BuckM, HouglumK, ChojkierM.Activation of hepatic stellate cells by TGFa and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest1995;96:2461–8.
33.
BedossaP, HouglumK, TrautweinC, HolstegeA, ChojkierM.Stimulation of collagen a (I) gene expression is associated with lipid peroxidation in hepatocellular injury. A link to tissue fibrosis?Hepatology1994;19:1262–71.
34.
ParolaM, MuracaR, DianzaniI, BarreraG, LeonarduzziG, BendinelliP, PiccolettiR, PoliG.Vitamin E dietary supplementation inhibits transforming growth factor ß1 gene expression in the rat liver. FEBS Lett1992;308:267–70.
35.
ParolaM, LeonarduzziG, BiasiF, AlbanoE, BioccaME, PoliG, DianzaniMU.Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology1992;16:1014–21.
36.
PietrangeloA, GualdiR, CasalgrandiG, MontosiG, VenturaE.Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest1995;1824–31.
37.
HouglumK, VenkataramaniA, LycheK, ChojkierM.A pilot study of the effects of d-a-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology1997;113:1069–73.
